generated recombinant Danio rerio α3(IV)NC1 domain. In contrast to recombinant human α3(IV)NC1 domain, there was complete absence of autoantibody binding to recombinant Danio rerio α3(IV)NC1. 3D molecular modeling from existing x-ray co-ordinates of human NC1 domain suggest that evolutionary alteration of electrostatic charge and polarity due to the emergence of critical serine, aspartic acid and lysine residues, accompanied by the loss of asparagine and glutamine contributes to the emergence of the two major Goodpasture's epitopes on the human α3(IV)NC1 domain, as it evolved from the Danio rerio over 450 million years.
only.
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INTRODUCTION
Type IV collagen is the most abundant protein within all basement membranes (BM) 1 . This collagen is present in most multi-cellular organisms, and thus is an evolutionary constant 2, 3 . In the BM, type IV collagen forms a network, which other basement membrane molecules attach to or become sequestered within 1, 4 . Type IV collagen in humans and mice is composed of six distinct α-chain gene products, α1(IV)-α6(IV). The α1(IV) and α2(IV)-chains are ubiquitously present in most organs, while the α3(IV)-α6(IV)-chains exhibit more restricted distributions and are present mostly in BMs with special functional roles, such as the kidney glomerular basement membrane (GBM) 1, [5] [6] [7] .
The α3-chain of type IV collagen is found in the kidney GBM, the alveolar BM of the lung, the basement membranes of the inner ear and the testis 1, 8 and is present in most mammals 9 .
Mice deficient in the α3(IV)-chain die due to renal failure as this protein is required for the proper function of the GBM 10, 11 . This phenotype resembles human Alport syndrome, a disease affecting kidneys and the inner ear, which results from mutations in the α3-chain, the α4-chain or the α5-chain of type IV collagen 8, 10 . Pathogenic autoantibodies directed against the NC1 domain of the α3-chain of type IV collagen (Goodpasture's autoantigen) are associated with human Goodpasture's syndrome (GP), a disease characterized by rapidly progressive glomerulonephritis and lung hemorrhage 8, [12] [13] . These autoantibodies are targeted to specific amino acid sequences within the NC1 domain of the α3(IV)-chain 8, 14 . By using mutagenesis analysis, it is known that a majority of the autoantibodies are directed against two distinct epitopes on the α3(IV)NC1 domain, namely epitopes E A and E B 15-18 . Epitope E A appears to be the immunodominant epitope, as the majority of patients' antibodies are directed against this site 18 . While the production of IgG1 and IgG3 subclasses of α3(IV) autoantibodies is considered to be the pathogenic feature of Goodpasture's syndrome, there is also strong evidence now for the role of T-cells in the initiation only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 4 of the disease [19] [20] [21] [22] [23] [24] [25] [26] . Therefore, in the past few years, Goodpasture's Syndrome has emerged as a classic autoimmune vascular disease mediated by B-cells [27] [28] [29] and T-cells [19] [20] [21] [22] [23] [24] [25] [26] , and immunosuppression in conjunction with plasmapheresis remains the most effective therapy 30 .
Since the vast majority of autoantibodies bind to the immunodominant epitope E A and epitope E B , several studies have sought to elucidate the key residues in these sites. Such studies have been primarily focused on epitope E A because this site is capable of inducing disease in rodents (14) . The method most commonly employed has been to recombinantly produce chimeric proteins [15] [16] [17] [18] [31] [32] . Many of these chimeric proteins are comprised of amino acids of the epitope E A from the α3(IV) NC1 domain with site-specific substitutions of analogous residues from the α1(IV)NC1 domain 17, [31] [32] . Such proteins were subsequently tested for their binding to autoantibodies from Goodpasture's patients, thus identifying putative critical amino acids that comprise the Goodpasture's epitope.
While others have employed site directed mutagenesis and chimeric protein analysis as a way to identify the critical amino acids within the Goodpasture's epitopes, we hypothesized that evolutionary changes over 450 million years 33 in the amino acids within the α3(IV)NC1 domains might offer insight into the unique amino acid residues that comprise the B-cell epitope for Goodpasture's autoantibodies. Comparative type IV collagen NC1 sequence analysis between nine species from C. elegans to humans, BM extraction, NC1 domain analysis from different species, cloning and recombinant protein production were used to identify the critical amino acids within the B-cell epitopes of the Goodpasture's autoantigen. This study provides a strategy to identify critical amino acids responsible for Goodpasture's autoantibody binding and offers new insights into potential therapeutic alternatives. A precise identification of amino acids responsible for autoimmunity will help design cell-mediated therapies to potentially impart systemic tolerance to pathogenic epitopes associated with this devastating disease. Recombinant protein production -The following PCR primers were designed to amplify a cDNA encoding the full-length Danio rerio α3(IV)NC1 which we have termed zα3(IV)NC1; 5' TCA CCA GGT GCA AAG CTT CCA CAA 3' and 5' TCT GTT CTC GAG TTT GGC GGT TTG 3'. The underlined sequence indicates the Hind III and Xho I restriction sites that were used for subsequent cloning of the generated cDNA fragment. The Hind III/Xho I fragment of the amplified product was cloned into the pcBFT expression vector containing the CMV promoter, the BM-40 signal peptide and a FLAG tag 34 . 293 human embryonic kidney cells were transfected with the plasmid using the 293 Fectin ® -system (Invitrogen) according to manufacturer's protocol.
Recombinant zα3(IV)NC1 was secreted into the culture supernatant as a fusion protein with the FLAG epitope. Supernatant containing protein was collected 24 hours post-transfection.
Recombinant human α3(IV)NC1 production was described earlier 34 . Western Blotting and antibodies -All western blots were performed on either 10% or 15% SDS polyacrylamide gels (SDS-PAGE) (Bio-Rad) under reducing or non-reducing conditions. Gels were transferred to nitrocellulose and incubated with sera, primary and secondary antibodies at the appropriate dilutions. The following primary antibodies were used; anti-α3(IV)-36mer antibody at 1:7500 dilution
Histology and Immunofluorescence
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, two separate α3(IV)NC1 antibodies 27 , three confirmed Goodpasture's patient sera at 1:20 dilution 36 and anti-FLAG M2 antibody at 1:1000 dilution (Sigma). In addition, two normal human sera were used as negative controls at the same dilutions as the Goodpasture's sera (data not shown). Anti-human IgG and anti-rabbit IgG HRP (Sigma) conjugated secondary antibodies were used at 1:1000 dilutions. ECL reagent for peroxidase substrate (Amersham Biosciences) was used to visualize antibody binding by exposure to x-ray film (Denville). 
Molecular Graphics
RESULTS AND DISCUSSION
The emergence of the Goodpasture's epitope -To study the binding of Goodpasture's autoantibodies, we extracted NC1 domains from BM extracts using bacterial collagenase from the following species: mouse, chicken, Xenopus laevis, Danio rerio, Drosophila and C. elegans. For the higher vertebrate organisms, kidney tissue was used as a source of BM, whereas for Drosophila and C. elegans whole organism BM extracts were utilized. Type IV collagen NC1 domains were successfully extracted from all organisms as shown by SDS-PAGE analysis and Western blot evaluation under reducing conditions ( Fig. 1A-B) . When analyzing Goodpasture's autoantibody reactivity to the isolated BM extracts under non-reducing conditions, positive binding of sera to α3(IV)-chain dimers and monomers could be observed in mouse, chicken and Xenopus (Fig. 1C) . Interestingly, binding to dimers was stronger than to monomers, as others have described 9 . (Fig. 1C) . The Goodpasture's epitope is considered to be sensitive to conformational changes and thus complete reduction of disulfide bonds β-mercaptoethanol leads to a total loss of antibody binding ( Fig. 1E) , while incomplete reduction with leads to stronger binding to α3(IV)NC1 monomers in all species (Fig. 1D) . Reactivity with Goodpasture's sera could not be observed with NC1 domains extracted from Danio rerio, C. elegans and Drosophila (Fig. 1C) . In Drosophila and C. elegans both α1(IV)-like and α2(IV)-like genes have been described [38] [39] [40] , but our genomic database analysis and cloning attempts suggest that an α3(IV)
gene does not appear to be present. Interestingly, our database search indicates that Danio rerio has six type IV collagen α-chains similar to higher organisms (MacDonald, B. et al.: unpublished data). However, while the Danio rerio α3(IV) gene was identified in our database search, the native NC1 domain extracts do not bind to Goodpasture's autoantibodies (Fig. 1C) .
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From Cloning, sequencing and recombinant expression of the Danio rerio α3(IV)-chain NC1 domain -Our results suggest that while the α3(IV)-chain is present in the Danio rerio (by inference from genomic database sequences), the NC1 domain extract from BM preparations of Danio rerio renal tissue does not bind to Goodpasture's autoantibodies. To further evaluate the capacity of the Danio rerio α3(IV)NC1 domain to bind these antibodies, we attempted to clone and generate recombinant protein.
In order to clone the Danio rerio α3(IV)NC1 domain (zα3(IV)NC1), we isolated total RNA from Danio rerio embryos and generated a collection of cDNAs by reverse transcription (RT), using oligo dTs as primers for the reaction. These cDNAs were subsequently used as a template to obtain the zα3(IV)NC1 domain by PCR. Gene specific PCR primers were designed using sequence data information obtained from the project Ensembl database. We successfully generated a 821 bp cDNA fragment, and sequencing verified that the cloned cDNA fragment contained 23 bp of the collagenous region, 702 bp containing the entire NC1 domain, and 96 bp of non-coding sequence. The nucleotide and amino acid sequence of zα3(IV)NC1 is shown in Fig. 2A . The homology of the five exons encoding the overall nucleotide and amino acid sequence of the zα3(IV)NC1, when compared to human α3(IV)NC1, is 60% and 74%, respectively. The twelve cysteines known to be essential for the appropriate conformational folding of the type IV collagen NC1 structure 41 are all conserved in zα3(IV)NC1 ( Fig. 2A) .
Interestingly, a methionine and a lysine residue, potentially involved in a novel non-disulfide covalent crosslink 37 are also conserved in the zα3(IV)NC1 (Fig. 2A) .
The cloned cDNA fragment was subsequently transferred to the pcBFT expression vector and transfected into 293 human embryonic kidney cells to produce recombinant zα3(IV)NC1 using a BM-40 signal peptide to enable extracellular secretion. Recombinant FLAG-tagged zα3(IV)NC1 fusion protein in the culture supernatants was analyzed by SDS-PAGE. Western blot analysis using antibodies directed against the FLAG-tag and the human α3(IV)NC1, verified the only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 11 recombinant expression of zα3(IV)NC1 monomers at the predicted molecular weight of approximately 29.4 kDa (zα3(IV)NC1+FLAG-tag) (Fig. 2B) . However, zα3(IV)NC1 did not bind to Goodpasture's autoantibodies from three different patients with clinical disease (Fig. 2C) , despite prolonged incubation with high concentrations of the autoantibodies to detect even weak binding. However, as shown earlier, strong binding of anti-human α3(IV)NC1 polyclonal antibodies to isolated native zNC1 domain monomers, dimers and trimers from BM extracts were observed (Fig. 2C) . Under reducing conditions the higher molecular weight trimers were lost and monomers of Danio rerio α3(IV)NC1 revealed stronger binding (Fig. 2C) . However, binding with the Goodpasture's sera to the isolated Danio rerio NC1 domains could be not observed, as shown earlier (Fig. 2D) . Together, these results demonstrate that although Danio rerio contains the encoding gene and the α3-chain of type IV collagen protein, the protein does not possess the capacity to bind Goodpasture's autoantibodies. Immunohistochemical localization of the zα3(IV)-chain in tissues was performed using two separate antibodies directed against the human α3(IV)NC1 domain. Identical results were obtained with both antibodies (Fig. 3 and data not shown) . The α3(IV)-chain in Danio rerio is strongly expressed in the gills and the kidney (Fig. 3B-D) . Gills are the fish equivalent of lungs, and the lungs and kidney are the sites of high expression of the α3(IV)-chain in mouse and humans 1, [5] [6] [7] . On the other hand, we could not observe any expression of the α3(IV)-chain in
Danio rerio testis (data not shown), although in mammals it is a site with high α3(IV) expression 1, [5] [6] [7] 42 . In the gills the α3(IV)-chain appeared to be expressed in the BM underlying the only.
For (Fig. 3A-B) . In the Danio rerio, the kidney morphology is distinct from that of higher organisms as it is also the site of hematopoiesis, in addition to its function in ultrafiltration (Fig. 3C) . In Danio rerio kidney the α3(IV)-chain is expressed in both the BM of the glomeruli as well as some tubules (Fig. 3D) . Interestingly, we could also observe strong staining of the α3(IV)-chain in the hematopoietic tissue (Fig. 3D) . In higher organisms, the α3(IV)-chain is an important component of the GBM in the kidney and is also expressed in some tubular BMs 6 . However, the potential role of this molecule in hematopoiesis is unknown. As observed in humans and other mammals, we were unable to detect zα3(IV)NC1 in liver, and stomach basement membranes.
Comparison of the Goodpasture's epitope sequences within the α 3(IV)NC1 among different organisms -Goodpasture's autoantibodies bind to human and chicken α3(IV)NC1
domains, but do not bind to the Danio rerio α3(IV)NC1 domain. In order to explain observed differences in Goodpasture's autoantibody binding, we compared amino acid sequences at the two putative B-cell Goodpasture's epitope regions, E A and E B, among different species (Fig. 4A-B) . The Danio rerio and chicken sequence analysis reveals that while most amino acids are conserved, some critical changes can be noticed, which are further preserved in the human sequence. Our results demonstrate that Goodpasture's antibody binding at epitope E A on the human α3(IV)NC1 domain requires conservation of threonine-17 (T17) and the presence of serine-21 (S21). Binding at epitope E B requires threonine-127 (T127), loss of asparagine-128 (N128), substitution of proline or alanine for glutamine-131(Q131), and lysine-141 (K141). This analysis is the first to show that T127 and K141 are important residues for antibody binding at Goodpasture's epitope E B .
Interestingly, while many species are positive for Goodpasture's autoantibody binding, they do not contain all of the amino acids previously determined to be critical for such activity by 17, 32 . Previous work also reinforces the importance of S21. By altering this residue in a chimeric construct, autoantibody recognition by 100% of patient serum samples decreases to 25% 17 . At epitope E B , similar mutational analysis has not been described.
All of the α3(IV) sequences, whether positive or negative for Goodpasture's sera binding, share the following sequence homology in epitope E A ; TxxPxCPxGTxxLYx, ( Fig. 4A and 5A). Cross-species conservation indicates that this sequence motif is evolutionarily preserved for structure or function. A similar conserved sequence motif, TxxPxCPxGWxSLWx ( and tyrosine (Y), and one additionally conserved C-terminal serine residue (S138).
Molecular modeling for 3D analysis of the human, chicken and Danio rerio α 3(IV)NC1
domains -In order to spatially evaluate charge, hydropathy and side-chain polarity of the epitope E A and E B sequence in the context of the entire NC1 domain, we utilized molecular modeling software and the existing human type IV collagen NC1 domain crystal structure to generate only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 14 models (Fig. 5A-G) . From crystallographic data it has been shown that the α1(IV)NC1 and α2(IV)NC1-chains are folded virtually identically, and their topologies very closely resemble one another 37 . Based on the high sequence identity between all type IV collagen NC1 domains, the α3(IV)NC1 domain is expected to fold with the same topology as the α1(IV)NC1
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. Therefore, by aligning the α3(IV)NC1 and α1(IV)NC1 sequences and using the known [(α1) 2 α2] 2 NC1
hexamer structure (Protein Data Base ID 1LI1), we have modeled amino acids that are divergent in the Danio rerio, chicken and human E A and E B epitope regions on a backbone homology α3(IV)NC1 structure (Fig. 5B-D) . Amino acid differences in epitope E A (blue) and E B (green) regions in chicken compared to Danio rerio are indicated by side chain rendering in yellow, while further amino acid differences in human compared to chicken are shown by side chain rendering in red (Fig. 5E-G) .
We found that in the context of the three-dimensional α3(IV) NC1 domain homology structures, residues that we identified as important in Goodpasture's autoantibody binding at epitopes E A and E B are localized to the outer loops of the epitopes (Fig. 5E-G) . In addition, many of these residue changes alter electrostatic potentials in these solvent exposed epitope regions. For example, S21
and K141, described above as important for epitope E A and E B binding, respectively, are glutamate residues in the immuno-negative Danio rerio.
The 3D homology structures enabled us to assess conserved α3(IV) NC1 residues immediately proximal to epitope E A . Glutamine 57 (Q57) is conserved in all immuno-positive proteins, but absent from all immuno-negative proteins, including Danio rerio α3(IV) NC1.
Surprisingly, although 26 residues away from epitope E A , in the tertiary NC1 domain structure, Q57 is immediately adjacent to epitope E A (Fig. 5F,G 
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Our combined findings prompted us to map the amino acid character and molecular surface of species-variable residues (non-conserved) onto the modeled Danio rerio, chicken and human E A and E B epitope regions of our backbone homology α3(IV)NC1 structures (Fig. 5B-D) .
Using color-coded amino acid character maps, it is readily apparent that in both E A and E B electrostatic charge and polarity changes are important in Goodpasture's autoantibody binding. A significant loss of electrostatic potential (positive/basic residue character) accompanies autoantibody recognition in the E A epitope region. The adjacent K27, R28 residue pair in Danio rerio is either a hydrophilic/polar residue as in chicken or hydrophobic/non-polar residue as in human. Overall, the immuno-positive chicken and human E A domains have reduced electrostatic potential and greater hydrophilic character, as compared to the homologous region in Danio rerio (Fig. 5B-D) . In contrast, the gain of a positive/basic residue in the epitope E B C-terminus is important for autoantibody binding (Fig. 5A-G) . K141 is one of two residue changes in epitope E B in chicken compared to Danio rerio that is present in human. The other residue change in epitope E B in chicken compared to Danio rerio that is also in human is T127. This substitution decreases the non-polar character of the epitope E B N-terminus. In summary, these comparisons demonstrate that evolutionary alterations of electrostatic charge and polarity contribute to Goodpasture's autoantibody binding in the α3(IV)NC1 E A and E B epitopes.
Interestingly, we found that the high hydrophobic character of both the E A and E B domains is largely conserved from Danio rerio to chicken to human. In previous studies, both V27 and P28 were shown to be important for antibody binding and critical residues of the E A autoepitope 17, 31, 43 , through mutagenic and chimeric analysis between α1(IV)NC1 and α3(IV)NC1
sequences (in human α1(IV) these residues are lysine and isoleucine). Examination of the corresponding residues in chicken, serine and glutamine, lessens the idea that V27 and P28 are important in epitope E A for hydrophobic contributions, and suggests that the reduced antibody binding observed in mutagenic/chimeric analyses possibly reflects the effects of basic charge only.
For
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insertion and side-chain steric clash (Fig. 5A-D) . Of note, one variable (non-conserved) hydrophobic residue at position 131 appears important for the E B antibody recognition site (Fig.   5A-D) . In Danio rerio a glutamine occurs at this position, while there is a transition to alanine in chicken and proline in human. Interestingly, a non-polar/hydrophobic residue type was conserved at position 137 (isoleucine/leucine/valine) in epitope E B between Danio rerio, chicken and human. The immuno-negative sequences of bovine α1(IV)NC1, and Drosophila and C. elegans α1(IV)NC1 and α2(IV)NC1 contain glutamate or serine at position 137. This finding suggests that a non-polar/hydrophobic residue at position 137 may be involved in autoantibody binding, but is not sufficient in the context of the Danio rerio E B region to impart antibody binding.
Our results demonstrate that there has been an evolutionary pressure to obtain the α3-chain of type IV collagen in the Danio rerio. This could be linked to the required homeostasis and physiology of vertebrates to exercise greater regulation of fluid and gas exchanges. Interestingly, the Goodpasture's epitope is not present within the α3(IV)NC1 domain of Danio rerio. The emergence of this epitope (in frogs) coincides with the transfer from aquatic to terrestrial living.
Lastly, our study demonstrates the importance of Danio rerio in elucidating the evolutionary changes within the α3(IV)NC1 domain, being the only species to possess an α3 chain of type IV collagen not recognized by Goodpasture's autoantibodies. This insight into the critical amino acids required for binding autoantibodies will potentially lead to cell-mediated therapies to impart systemic tolerance to the pathogenic epitopes which cause this devastating disease. Future studies will hopefully shed more light on the physiological need for such modification in the α3-chain of type IV collagen. Reduction of the samples eliminates the conformational structure of the Goodpasture's epitope.
With slight reduction (1.5% β-mercaptoethanol) some monomer (M) from each of the three positive species native NC1s was recognized by the Goodpasture's sera. E. Under extreme reducing conditions (10% β mercaptoethanol), binding to all monomer and dimer forms of NC1 by Goodpasture's sera was eliminated, as expected and previously described 17 . domain backbone is shown in ribbon representation (grey). E-G. The peptide backbone from residues 17-31 (using human α3(IV) numbering) in the α3(IV)-chain corresponding to the E A epitope region is colored blue, and from 125-139 corresponding to the E B epitope region is colored green. Non-conserved residues in E A and E B are shown with rendered side chains, and identified by single letter residue code. Sequence differences between the Danio rerio and chicken E A and E B epitopes are highlighted in yellow on the chicken homology α3(IV)NC1 domain structure. Additionally, sequence differences between the chicken and human E A and E B epitope regions are highlighted further in red on the human homology α3(IV)NC1 domain structure. The Q57 critical in forming the conformational, discontinuous epitope E A is colored magenta.
